Lane Annah, Vivian Philip, Coulthard Alan
Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
J Med Imaging Radiat Oncol. 2015 Apr;59(2):163-9. doi: 10.1111/1754-9485.12288.
Endovascular treatment of intracranial aneurysms is now common. Digital subtraction catheter angiography (DSA) is the gold standard for imaging follow-up of coiled intracranial aneurysms; however, it is an invasive procedure with a risk of complications. Time-of-flight magnetic resonance angiography (MRA) is an alternative non-invasive imaging method. In a previous study, we found that MRA at 1.5T was comparable to DSA for detection of aneurysm recurrence in this patient group and subsequently added MRA to the routine follow-up protocol. In the current study, we further compare MRA with DSA to determine whether MRA could safely replace DSA.
Patients who had endovascular coiling procedure for intracranial aneurysm from 10/2004 to 6/2010 were identified from our database. A radiologist and a radiology registrar compared MRA and DSA for all patients who received both modalities. DSA was considered as the reference technique. 'Agreement' or 'disagreement' between modalities was noted regarding absence or presence of aneurysm recurrence.
The study group comprised 86 treatments of 80 aneurysms in 73 patients. There were 83/86 agreements between modalities and 3 disagreements. In one case, MRA identified a recurrence that was not seen on the corresponding DSA. In two cases, DSA showed a minor recurrence that was not seen on MRA.
Of the two MRA 'misses', neither would have resulted in different management. MRA is a safe and accurate modality for follow-up of coiled aneurysms and can replace DSA.
颅内动脉瘤的血管内治疗如今已很常见。数字减影导管血管造影术(DSA)是颅内动脉瘤栓塞术后影像随访的金标准;然而,它是一种侵入性操作,存在并发症风险。时间飞跃磁共振血管造影术(MRA)是一种替代性的非侵入性成像方法。在之前的一项研究中,我们发现1.5T的MRA在检测该患者群体的动脉瘤复发方面与DSA相当,随后将MRA纳入了常规随访方案。在本研究中,我们进一步比较MRA和DSA,以确定MRA是否能安全地替代DSA。
从我们的数据库中识别出2004年10月至2010年6月期间接受颅内动脉瘤血管内栓塞治疗的患者。一名放射科医生和一名放射科住院医师对所有接受了这两种检查的患者的MRA和DSA进行了比较。DSA被视为参考技术。记录两种检查方式在动脉瘤复发与否方面的“一致”或“不一致”情况。
研究组包括73例患者的80个动脉瘤的86次治疗。两种检查方式有83/86次结果一致,3次不一致。在1例中,MRA发现了相应DSA上未显示的复发。在2例中,DSA显示了MRA上未发现的轻微复发。
在MRA“漏诊”的2例中,均不会导致治疗方式的不同。MRA是颅内动脉瘤栓塞术后随访的一种安全且准确的检查方式,可替代DSA。